Current applications of health-related quality-of-life assessment in oncology

被引:0
作者
Osoba D. [1 ]
机构
[1] Quality of Life Program, British Columbia Cancer Agency, Vancouver
关键词
Cancer; Clinical trials; Health-related quality-of-life;
D O I
10.1007/BF01262565
中图分类号
学科分类号
摘要
The past 5 years have seen increasing application of health-related quality-of-life (HRQOL) assessment in ontology. Most commonly, HRQOL has been studied in patients with me tastatic cancer and in trials involving the use of antiemetics to control postchemotherapy nausea and vomiting. These studies have produced interesting and, in some cases, counterintuitive results. Thus far, HRQOL assessment appears to be important in clinical trials involving control of symptoms (disease-related or treatment-related), cancers with a poor prognosis, treatment arms with similar survivals, supportive care interventions, and ways of determining prognosis.
引用
收藏
页码:100 / 104
页数:4
相关论文
共 10 条
[1]  
Coates A., Gebski V., Bishop J.F., Et al., Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies, N Engl J Med, 317, pp. 1490-1495, (1987)
[2]  
Coates A., Gebski V., Signorini D., Et al., Prognostic value of qualityof-life scores during chemotherapy for advanced breast cancer, J Clin Oncol, 10, pp. 1833-1838, (1992)
[3]  
Ganz P.A., Coscarelli Schag C.A., Lee J.J., Et al., Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery?, Cancer, 69, pp. 1729-1738, (1992)
[4]  
Lindley C.M., Hirsch J.D., O'Neill C.V., Et al., Quality of life consequences of chemotherapy-induced emesis, Qual Life Res, 1, pp. 331-340, (1992)
[5]  
O'Brien B.J., Rusthoven J., Rocchi A., Et al., Impact of chemotherapyassociated nausea and vomiting on patients' functional status and costs, Can Med Assoc J, 149, pp. 296-302, (1993)
[6]  
Osoba D., Zee B., Warr D., Et al., Quality of life studies in chemotherapy-induced emesis, Oncology, 53, 1 SUPPL., pp. 92-95, (1996)
[7]  
Osoba D., Zee B., Pater J., Et al., Determinants of postchemotherapy nausea and vomiting in patients with cancer, J Clin Oncol, (1996)
[8]  
Ovesen L., Allingstrup L., Hannibal J., Et al., Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: A prospective, randomized study, J Clin Oncol, 11, pp. 2043-2049, (1993)
[9]  
Pater J., Slamet L., Zee B., Et al., Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting, Support Care Cancer, 2, pp. 161-166, (1994)
[10]  
Tannock I.F., Osoba D., Stockier M.R., Et al., Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormoneresistant prostate cancer: A Canadian randomized trial with palliative end points, J Clin Oncol, 14, pp. 1756-1764, (1996)